Rituximab therapy improves recalcitrant Pemphigus vulgaris

Pemphigus is a severe life-threatening blistering disease associated with autoantibodies against cell adhesion proteins desmogleins 1 and 3. Patients with severe pemphigus commonly show high rates of relapse after conventional immunosuppressive therapy. The newly developed drug Rituximab showed impr...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:EXCLI J
Egile Nagusiak: Noormohammadpour, Pedram, Ehsani, Amirhooshang, Mortazavi, Hossein, Daneshpazhooh, Maryam, Balighi, Kamran, Mofidi, Mohammad, Gholamali, Fatemeh, Sadeghinia, Ali
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Leibniz Research Centre for Working Environment and Human Factors 2015
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4553899/
https://ncbi.nlm.nih.gov/pubmed/26417354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17179/excli2014-603
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak